This inventor holds 3 USPTO granted patents. Top assignees: Baylor University, Oxigene, Inc.. Active years: 2005-2006.
Company Filing History:
3 out of 200 
2 out of 25 
Years Active: 2005-2006
Title: The Innovative Contributions of Mallinath Hadimani
Introduction
Mallinath Hadimani is a notable inventor based in Waco, Texas, recognized for his significant contributions to the field of medicinal chemistry. With a total of three patents to his name, Hadimani has focused on developing innovative solutions for targeting tumor cell vasculature.
Latest Patents
His latest patents include "Tubulin binding ligands and corresponding prodrug constructs," which describe a diverse set of tubulin binding agents. These agents are characterized by a semi-rigid molecular framework that maintains aryl-aryl, pseudo pi stacking distances suitable for molecular recognition of tubulin. In their phenolic or amino forms, these ligands can be further functionalized to create phosphate esters, phosphate salts, phosphoramidates, and other prodrugs. These compounds are designed to demonstrate selective targeting and destruction of tumor cell vasculature.
Career Highlights
Throughout his career, Hadimani has worked with esteemed organizations such as Baylor University and Oxigene, Inc. His work has contributed to advancements in cancer treatment methodologies, particularly through the development of targeted therapies.
Collaborations
Some of his notable coworkers include Kevin G. Pinney and Vani P. Mocharla, who have collaborated with him on various projects aimed at enhancing the efficacy of cancer treatments.
Conclusion
Mallinath Hadimani's innovative work in the field of medicinal chemistry has led to the development of promising therapeutic agents for cancer treatment. His contributions continue to impact the scientific community and offer hope for improved cancer therapies.